Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Nature Genetics
|
March 4, 2014
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel, Justine E Roderick, Kaylyn E Williamson, et al.
Leukemia
|
January 14, 2022
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma
Johannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Kenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 21, 2012
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G Lohr, Petar Stojanov, Michael S Lawrence, et al.
Nature Biotechnology
|
April 23, 2014
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G Lohr, Viktor A Adalsteinsson, Kristian Cibulskis, et al.
Nature Communications
|
November 8, 2017
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Nature Genetics
|
March 4, 2014
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel, Justine E Roderick, Kaylyn E Williamson, et al.
Leukemia
|
January 14, 2022
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma
Johannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Kenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 21, 2012
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G Lohr, Petar Stojanov, Michael S Lawrence, et al.
Nature Biotechnology
|
April 23, 2014
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G Lohr, Viktor A Adalsteinsson, Kristian Cibulskis, et al.
Nature Communications
|
November 8, 2017
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, et al.
Page
of 6